European Society of Gene and Cell Therapy (ESGCT)
The European Society of Gene and Cell Therapy (ESGCT) was founded in 1992, and its annual congress brings together experts in the field of gene and cell therapy to share the latest understanding and developments of these treatments.
Please select the resource of interest below:
|
Eladocagene Exuparvovec is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system. Adverse events should also be reported to PTC Therapeutics at pharmacovigilance@ptcbio.com.Registration conditions differ internationally; always consult local prescribing information and/or Summary of Product Characteristics before prescribing any products.
MED-ALL-PTC-AADC-2500006 | September 2025
MED-ALL-AADC-2200032 | June 2025